When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer Aspirin

Klaus Jennewein, Thomas Durand () and Alexander Gerybadze
Additional contact information
Klaus Jennewein: DT Lab - Deutsche Telekom Laboratories - Deutsche Telekom
Thomas Durand: CNAM - Conservatoire National des Arts et Métiers [CNAM], Ecole Centrale Paris
Alexander Gerybadze: Universität Hohenheim = University of Hohenheim

Post-Print from HAL

Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Published in Management international = International management = Gestión internacional, 2010, 14 (3), pp.73. ⟨10.7202/044294ar⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02122742

DOI: 10.7202/044294ar

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().